Legal Representation
Attorney
Bret E. Field
USPTO Deadlines
Application History
50 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Dec 31, 2018 | MAB6 | E | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED | Loading... |
| Dec 31, 2018 | ABN6 | S | ABANDONMENT - NO USE STATEMENT FILED | Loading... |
| May 24, 2018 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| May 23, 2018 | EX5G | S | SOU EXTENSION 5 GRANTED | Loading... |
| May 21, 2018 | EXT5 | S | SOU EXTENSION 5 FILED | Loading... |
| May 21, 2018 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Nov 21, 2017 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Nov 17, 2017 | EX4G | S | SOU EXTENSION 4 GRANTED | Loading... |
| Nov 17, 2017 | EXT4 | S | SOU EXTENSION 4 FILED | Loading... |
| Nov 17, 2017 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| May 20, 2017 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| May 18, 2017 | EX3G | S | SOU EXTENSION 3 GRANTED | Loading... |
| May 18, 2017 | EXT3 | S | SOU EXTENSION 3 FILED | Loading... |
| May 18, 2017 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Jan 9, 2017 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
| Dec 3, 2016 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Dec 2, 2016 | EX2G | S | SOU EXTENSION 2 GRANTED | Loading... |
| Nov 15, 2016 | EXT2 | S | SOU EXTENSION 2 FILED | Loading... |
| Dec 1, 2016 | AITU | A | CASE ASSIGNED TO INTENT TO USE PARALEGAL | Loading... |
| Nov 15, 2016 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Apr 28, 2016 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Apr 26, 2016 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
| Apr 26, 2016 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
| Apr 26, 2016 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Nov 24, 2015 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Sep 29, 2015 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Sep 29, 2015 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Sep 9, 2015 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Aug 21, 2015 | PREV | O | LAW OFFICE PUBLICATION REVIEW COMPLETED | Loading... |
| Aug 17, 2015 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Jul 31, 2015 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Jul 31, 2015 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Jul 23, 2015 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Jul 7, 2015 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Jul 7, 2015 | GNRT | O | NON-FINAL ACTION E-MAILED | Loading... |
| Jul 7, 2015 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Jun 16, 2015 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Jun 16, 2015 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Jun 9, 2015 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Feb 26, 2015 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Feb 26, 2015 | GNRT | O | NON-FINAL ACTION E-MAILED | Loading... |
| Feb 26, 2015 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Feb 6, 2015 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Feb 6, 2015 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Feb 6, 2015 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Nov 4, 2014 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Nov 4, 2014 | GNRT | O | NON-FINAL ACTION E-MAILED | Loading... |
| Nov 4, 2014 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Oct 16, 2014 | ZZZX | Z | PREVIOUS ALLOWANCE COUNT WITHDRAWN | Loading... |
| Aug 19, 2014 | PBCR | Z | WITHDRAWN FROM PUB - OG REVIEW QUERY | Loading... |
Detailed Classifications
Class 003
Cosmetics; cosmetic preparations; adhesives for cosmetic purposes; cosmetic masks; soaps for personal use; perfumery; essential oils; hair lotions
First Use Anywhere:
0
First Use in Commerce:
0
Class 005
Pharmaceuticals for the treatment of cardiovascular conditions, allergies, central nervous system conditions, peripheral nervous system conditions, electrolytic imbalance, caloric imbalance, obesity, vitamin imbalance, gastrointestinal conditions, inflammation, dermatological conditions, infectious diseases, hormonal imbalance, pain, cancer conditions, pulmonary conditions, ophthalmic conditions, musculoskeletal conditions, diabetic conditions, psychosis, senile conditions, dementia, congenital disease conditions, abnormal gene conditions; pharmaceutical preparations, compositions, creams and lotions for the treatment of cardiovascular conditions, allergies, central nervous system conditions, peripheral nervous system conditions, electrolytic imbalance, caloric imbalance, obesity, vitamin imbalance, gastrointestinal conditions, inflammation, dermatological conditions, infectious diseases, hormonal imbalance, pain, cancer conditions, pulmonary conditions, ophthalmic conditions, musculoskeletal conditions, diabetic conditions, psychosis, senile conditions, dementia, congenital disease conditions, abnormal gene conditions; prescription and over-the-counter pharmaceutical preparations for the treatment of cardiovascular conditions, allergies, central nervous system conditions, peripheral nervous system conditions, electrolytic imbalance, caloric imbalance, obesity, vitamin imbalance, gastrointestinal conditions, inflammation, dermatological conditions, infectious diseases, hormonal imbalance, pain, cancer conditions, pulmonary conditions, ophthalmic conditions, musculoskeletal conditions, diabetic conditions, psychosis, senile conditions, dementia, congenital disease conditions, abnormal gene conditions; prescription and over-the-counter pharmaceutical preparations, namely, transdermal gel formulations, transdermal cream formulations, oral mucous formulations, transdermal patches, dressings and medical adhesive tapes for use in the treatment of cardiovascular conditions, allergies, central nervous system conditions, peripheral nervous system conditions, electrolytic imbalance, caloric imbalance, obesity, vitamin imbalance, gastrointestinal conditions, inflammation, dermatological conditions, infectious diseases, hormonal imbalance, pain, cancer conditions, pulmonary conditions, ophthalmic conditions, musculoskeletal conditions, diabetic conditions, psychosis, senile conditions, dementia, congenital disease conditions, abnormal gene conditions; pharmaceutical products, namely analgesics
First Use Anywhere:
0
First Use in Commerce:
0
Class 035
Wholesale and retail store services and online wholesale and retail store services featuring pharmaceutical products and medical devices for storage, application and disposal of pharmaceutical preparations; Retail and wholesale store services and online retail and wholesale store services featuring pharmaceutical preparations, veterinary preparations, sanitary preparations, and medical supplies for storage, application and disposable of pharmaceutical preparations
First Use Anywhere:
0
First Use in Commerce:
0
Class 042
Pharmaceutical research and development; pharmaceutical product evaluation, testing and inspection services; providing medical and scientific research information in the field of pharmaceuticals; information, advisory and consultancy services relating to pharmaceutical product evaluation, testing and inspection services
First Use Anywhere:
0
First Use in Commerce:
0
Additional Information
Design Mark
The mark consists of the wording "TPU PHARMA" with the each letter in "TPU" accented with one solid square. To the right of the wording "TPU" is the word "Pharma" which is accented with an overline and an underline.
Color Claim
Color is not claimed as a feature of the mark.
Classification
International Classes
003
005
035
042
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
General Disclaimer
"PHARMA"